Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet

Annals of Surgery

Volumn 249, Issue 2, 2009, Pages 269-276

  Warne, James P ^a   Padilla, Benjamin E ^a   Horneman, Hart F ^a   Ginsberg, Abigail B ^a   Pecoraro, Norman C ^a   Akana, Susan F ^a   Dallman, Mary F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCAGON; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DUODENUM JEJUNUM BYPASS; FECES ANALYSIS; FOOD INTAKE; GENE EXPRESSION; GLUCAGON BLOOD LEVEL; IN SITU HYBRIDIZATION; INSULIN SENSITIVITY; INTESTINE BYPASS; MALE; MESENTERY; METABOLIC REGULATION; NERVE TRANSECTION; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SURGICAL APPROACH; SURGICAL TECHNIQUE; VAGUS NERVE; WHITE ADIPOSE TISSUE; ANIMAL; DISEASE MODEL; EATING; INSULIN RESISTANCE; JEJUNOILEAL BYPASS; METABOLISM; MORBID OBESITY; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PERIOD; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; EATING; INSULIN RESISTANCE; INTESTINE, SMALL; JEJUNOILEAL BYPASS; MALE; NEUROSECRETORY SYSTEMS; OBESITY, MORBID; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 61549098114     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181961d5d     Document Type: Article

References (49)

1. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132:2253-2271.
2. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-350.
3. DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640-645.
4. MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213-220.
5. Cowan GS Jr, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987-992.
6. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care. 2006;9:497-507.
7. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006; 244:741-749.
8. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1-11.
9. Berthoud HR, Carlson NR, Powley TL. Topography of efferent vagal inner-vation of the rat gastrointestinal tract. Am J Physiol. 1991;260(1, pt 2):R200-R207.
10. Berthoud H-R, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000;85:1-17.
11. Warne JP, Foster MT, Horneman HF, et al. Hepatic branch vagotomy, like insulin replacement, promotes voluntary lard intake in streptozotocin-diabetic rats. Endocrinology. 2007;148:3288-3298.
12. Warne JP, Foster MT, Horneman HF, et al. Afferent signalling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. J Physiol. 2007;583(pt 2):455- 467.
13. Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec. 2004;280A:827-835.
14. Mei N. Vagal glucoreceptors in the small intestine of the cat. J Physiol. 1978;282:485-506.
15. Randich A, Spraggins DS, Cox JE, et al. Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity. Neuroreport. 2001;12:3101-3105.
16. Torii K, Niijima A. Effect of lysine on afferent activity of the hepatic branch of the vagus nerve in normal and L-lysine-deficient rats. Physiol Behav. 2001;72:685-690.
17. Wang PY, Caspi L, Lam CK, et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature. 2008;452:1012-1016.
18. Warne JP, Foster MT, Horneman HF, et al. The gastroduodenal branch of the common hepatic vagus regulates voluntary lard intake, fat deposition, and plasma metabolites in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab. 2008;294:E190-E200.
19. Meguid MM, Ramos EJ, Suzuki S, et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg. 2004;8:621-630.
20. Berg BN, Harmison CR. Growth, disease, and aging in the rat. J Gerontol. 1957;12:370-377.
21. Pecoraro N, Ginsberg AB, Warne JP, et al. Diverse basal and stress-related phenotypes of Sprague Dawley rats from three vendors. Physiol Behav. 2006;89:598-610.
22. Lo S, Russell JC, Taylor AW. Determination of glycogen in small tissue samples. J Appl Physiol. 1970;28:234-236.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
24. la Fleur SE, Akana SF, Manalo S, et al. Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores. Endocrinology. 2004;145:2174-2185.
25. Warne JP, Horneman HF, Wick EC, et al. Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight, and fat stores. Endocrinology. 2006;147:5443-5451.
26. la Fleur SE, Manalo S, Roy M, et al. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to streptozotocin-diabetes and voluntary lard ingestion. Eur J Neurosci. 2005;21:2733-2742.
27. Ginsberg AB, Campeau S, Day HE, et al. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or Fos protein expression in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol. 2003;15:1075-1083.
28. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 1998.
29. Miller DL. Rat small intestine: development, composition and effects of perfusion. Am J Dig Dis. 1971;16:247-254.
30. Rubino F, Zizzari P, Tomasetto C, et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 2005;146:1745-1751.
31. Warne JP, Horneman HF, Ginsberg AB, et al. Mapping brain c-Fos immunoreactivity after insulin-induced voluntary lard intake: insulin- and lardassociated patterns. J Neuroendocrinol. 2007;19:794-808.
32. Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194:221-224.
33. Hickey MS, Pories WJ, MacDonald KG Jr, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg. 1998;227: 637-643.
34. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
35. Cammisotto PG, Gingras D, Renaud C, et al. Secretion of soluble leptin receptors by exocrine and endocrine cells of the gastric mucosa. Am J Physiol Gastrointest Liver Physiol. 2006;290:G242-G249.
36. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature. 1998;394:790-793.
37. Cammisotto PG, Gingras D, Bendayan M. Transcytosis of gastric leptin through the rat duodenal mucosa. Am J Physiol Gastrointest Liver Physiol. 2007;293:G773-G779.
38. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530-532.
39. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-253.
40. Nadreau E, Baraboi ED, Samson P, et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond). 2006;30:419-429.
41. Heinrichs SC, Menzaghi F, Pich EM, et al. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 1993;611:18-24.
42. Benoit S, Schwartz MW, Baskin D, et al. CNS melanocortin system involvement in the regulation of food intake. Horm Behav. 2000;37:299-305.
43. King BM, Rossiter KN, Stines SG, et al. Amygdaloid-lesion hyperphagia: impaired response to caloric challenges and altered macronutrient selection. Am J Physiol. 1998;275:R485-R493.
44. Ciccocioppo R, Fedeli A, Economidou D, et al. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci. 2003;23: 9445-9551.
45. Savontaus E, Conwell IM, Wardlaw SL. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res. 2002;958:130-138.
46. Schwartz MW, Seeley RJ, Woods SC, et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 1997;46:2119-2123.
47. Warne JP, Horneman HF, Akana SF, et al. Insulin and the constituent branches of the hepatic vagus interact to modulate hypothalamic and limbic neuropeptide mRNA expression differentially. J Neuroendocrinol. 2008;20: 1067-1077.
48. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 2003;285:E685-E692.
49. Wang XM, Zhou Y, Spangler R, et al. Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in rat brain. Mol Brain Res. 1999;66:184-187.